All In Biotech

Drug Trial Radar · NCT03606395

Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression

Last checked: Nov 19, 2026Latest source record: Jul 9, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

80

Actual

Start

Jun 6, 2018

Primary completion

Jun 9, 2019

Study completion Jul 7, 2019

Sponsor

Lead sponsor
Navitor Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jul 30, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Randomized, two-part, placebo-controlled study of single ascending doses of NV-5138 in healthy volunteers, and a single dose of NV-5138 in subjects with Treatment-Resistant Depression (TRD)

Conditions

  • Treatment Resistant Depression

Interventions

  • NV-5138Drug

    single ascending dose

  • PlacebosDrug

    Placebo liquid solution to mimic NV-5138

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment-related adverse events as evidenced by CTCAE v.5.0Time frame: Baseline through Day 9

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Collaborative Neuroscience Network

    Long Beach, California

  • Synergy San Diego

    San Diego, California

  • MD Clinical

    Hallandale, Florida

  • Innovative Clinical Research Inc

    Hialeah, Florida

  • Research Centers of America

    Hollywood, Florida

  • St. Louis Clinical Trials

    St Louis, Missouri

  • Hassman Research Institute

    Berlin, New Jersey

  • Midwest Clinical Research

    Dayton, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.